🔎 Trials Near Me

Home › Thyroid Cancer › California › Los Angeles

Thyroid Cancer clinical trials in Los Angeles, CA

5 studies for Thyroid Cancer are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

RecruitingPhase 1/2
  • The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924

Active Surveillance of Papillary Thyroid Microcarcinoma

Recruiting
  • Cedars-Sinai Medical Center, Los Angeles
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT02609685

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

RecruitingPhase 1
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT04119024

Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer

RecruitingObservational study
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Ages 18 and older · All sexes · Updated Mar 10, 2026 · NCT04742608

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

RecruitingPhase 2
  • Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Ages 18 and older · All sexes · Updated Jun 27, 2025 · NCT03175224

About Thyroid Cancer

Your thyroid is a butterfly-shaped gland in your neck. There are several thyroid cancer types with different treatments. Discover options available.

More about Thyroid Cancer on MedlinePlus

Thyroid Cancer trials in other cities

Other studies in Los Angeles

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.